Meningococcal Conjugate Vaccine Schedule

Links shared publicly online about this topic

First Meningococcal A Conjugate Vaccine Launched In Burkina Faso

medicalnewstoday.com — “A vaccine that is expected to eradicate the primary cause of meningitis epidemic in Africa is being used across Burkina Faso, starting today, December 6th 2010. If all goes well it will then be usView full resource at medicalnewstoday.com

  • View Related
  • Share

Most Recently Shared on December 6, 2010 at 11:07 pm By:

medical_tweets medical_tweets Health News

First Meningococcal A Conjugate Vaccine Launched In Burkina Faso A vaccine that is expected to eradicate the primary ca.. http://dld.bz/99Up

1 year ago...

Pediatrics News & Articles - MDLinx - Meningococcal-C Conjugated Vaccine on #MDlinx

mdlinx.com — “Pediatrics News & Articles - MDLinx - Meningococcal-C Conjugated Vaccine on #MDlinxView full resource at mdlinx.com

  • View Related
  • Share

Most Recently Shared on August 17, 2010 at 6:35 am By:

MDLinx Sandeep Pulim MD Doctor, Health Communicator, and Physician

Antibody Persistence 12 Months After A Booster Dose of Meningococcal-C Conjugated Vaccine in the Second Year ... http://bit.ly/b37bLR #peds

1 year ago...

Meningococcal Conjugate Vaccines Policy Update: Booster Dose Recommendations

pediatrics.aappublications.org — “Meningococcal Conjugate Vaccines Policy Update: Booster Dose RecommendationsView full resource at pediatrics.aappublications.org

  • View Related
  • Share

Most Recently Shared on November 29, 2011 at 1:23 am By:

baby411 Dr. Ari Brown Doctor, Pediatrician, and Physician

It's official. 16 year olds need a booster dose of meningitis vaccine. http://t.co/u0Crjzhx

2 months ago...

FDA approves Sanofi Pasteur's meningococcal vaccine

news-medical.net — “Sanofi Pasteur, the vaccines division of the sanofi-aventis Group, announced today that the U.S. Food and Drug Administration has granted licensure to expand the indication for its meningococcal conjugate vaccine, Menactra, to include a two-dose schedule for infants and children 9 months through 23 months of age.View full resource at news-medical.net

  • View Related
  • Share

Most Recently Shared on April 25, 2011 at 11:44 am By:

Meningitis_News News-Medical.Net Health News

Meningitis News: FDA approves Sanofi Pasteur's meningococcal vaccine: Sanofi Pasteur, the vaccines division of t... http://bit.ly/eCrvvc

10 months ago...

FDA Approval Of Menactra Meningococcal Conjugate Vaccine Indication For Infants Announced By Sanofi Pasteur

medicalnewstoday.com — “Sanofi Pasteur, the vaccines division of the sanofi-aventis Group (EURONEXT: SAN and NYSE: SNY), announced today that the U.S. Food and Drug Administration (FDA) has granted licensure to expand thView full resource at medicalnewstoday.com

  • View Related
  • Share

Most Recently Shared on April 25, 2011 at 4:05 pm By:

mnt_vaccines MNT Vaccines Health News

FDA Approval Of Menactra Meningococcal Conjugate Vaccine Indication For Infants Announced By Sanofi Pasteur http://mnt.to/3TYW

10 months ago...

Updated Recommendations for Use of Meningococcal Conjugate Vaccines --- Advisory Committee on Immunization Practices (ACIP), 2010

cdc.gov — “Updated Recommendations for Use of Meningococcal Conjugate Vaccines --- Advisory Committee on Immunization Practices (ACIP), 2010View full resource at cdc.gov

  • View Related
  • Share

Most Recently Shared on January 28, 2011 at 2:49 pm By:

HealthTrendster HealthTrendster Health Executive

Updated Recommendations for Use of Meningococcal Conjugate Vaccines --- Advisory Committee on… http://goo.gl/fb/yXnsC

1 year ago...

AAP updates meningococcal vaccination recommendations

pediatricsupersite.com — “The American Academy of Pediatrics’ guidelines on the use of quadrivalent meningococcal conjugate vaccines are now in line with those recommendedView full resource at pediatricsupersite.com

  • View Related
  • Share

Most Recently Shared on December 2, 2011 at 1:43 pm By:

PedSuperSite Pediatric SuperSite Health Site

AAP updates meningococcal vaccination recommendations: http://t.co/CZfqs4Se

2 months ago...

FDA approves the Novartis quadrivalent meningococcal conjugate vaccine, Menveo®, for use in children from 2 years of age

novartis.com — “FDA approves the Novartis quadrivalent meningococcal conjugate vaccine, Menveo®, for use in children from 2 years of ageView full resource at novartis.com

  • View Related
  • Share

Most Recently Shared on January 31, 2011 at 2:19 pm By:

eyeonfda eyeonfda Health Lawyer and Pharma

FDA approves Novartis quadrivalent meningococcal conjugate vaccine, Menveo®, for use in children from 2 years of age - http://ow.ly/3NfGW

1 year ago...

Novartis receives approval in the European Union for Menveo, first quadrivalent conjugate vaccine in the EU to help prevent meningococcal disease

novartis.com — “Novartis receives approval in the European Union for Menveo, first quadrivalent conjugate vaccine in the EU to help prevent meningococcal diseaseView full resource at novartis.com

  • View Related
  • Share

Most Recently Shared on March 18, 2010 at 7:14 am By:

Novartis Novartis Pharma

Novartis Menveo is 1st quadrivalent conjugate vaccine approved in EU to help prevent meningococcal disease: http://bit.ly/cbKt7t

2 years ago...

This Week in Allergy & Immunology Mar 16 : Atrophic rhinosinusitis, Meningococcal Conjugate Vaccines, Inhaled corticosteroids | Facebook

facebook.com — “This Week in Medicine by Symposier wrote a note titled This Week in Allergy & Immunology Mar 16 : Atrophic rhinosinusitis, Meningococcal Conjugate Vaccines, Inhaled corticosteroids. Read the full text here.View full resource at facebook.com

  • View Related
  • Share

Most Recently Shared on March 16, 2011 at 11:30 pm By:

SympoPneumology Symposier Pneumology Support

This Week in Allergy & Immunology: Atrophic rhinosinusitis, Meningococcal Conjugate Vaccine, Inhaled corticosteroids http://on.fb.me/gP6mRv

11 months ago...

Sanofi Pasteur Announces FDA Approval of Menactra Meningococcal Conjugate Vaccine Indication for Infants - Apr 22, 2011

sanofipasteurus.mediaroom.com — “Welcome to sanofi pasteur, Sanofi Pasteur US Media Center, the vaccines division of sanofi-aventis Group, is the largest company in the world devoted entirely to human vaccines.View full resource at sanofipasteurus.mediaroom.com

  • View Related
  • Share

Most Recently Shared on April 26, 2011 at 8:43 am By:

sanofipasteur Sanofi Pasteur Pharma

Sanofi Pasteur Announces FDA Approval of #Menactra Meningococcal Conjugate #Vaccine Indication for Infants. http://ow.ly/4GYoo

10 months ago...

Oncology Article | Stem Cell Transplantation Meningococcal Vaccines

mdlinx.com — “Safety and Immunogenicity of the tetravalent protein-conjugated meningococcal vaccine (MCV4) in recipients of related and unrelated allogeneic stem cell transplantation (alloHCT)View full resource at mdlinx.com

  • View Related
  • Share

Most Recently Shared on August 8, 2011 at 10:43 am By:

MDLinx Sandeep Pulim MD Doctor, Health Communicator, and Physician

Safety and Immunogenicity of the tetravalent protein-conjugated meningococcal vaccine (MCV4) in recipi... http://bit.ly/qE3uzT #oncology

6 months ago...

New vaccine approved to prevent meningococcal disease

pediatricsupersite.com — “FDA officials have approved Novartis' quadrivalent meningococcal conjugate vaccine to prevent invasive meningococcal disease caused by NeisseriaView full resource at pediatricsupersite.com

  • View Related
  • Share

Most Recently Shared on February 23, 2010 at 3:00 pm By:

Meningococcal vaccines show improved efficacy but still problematic

pediatricsupersite.com — “ATLANTA — Meningococcal conjugate vaccines have been effective in reducing illness in the United Kingdom for the past decade, but waning imView full resource at pediatricsupersite.com

  • View Related
  • Share

Most Recently Shared on July 20, 2010 at 8:30 pm By:

PedSuperSite Pediatric SuperSite Health Site

Meningococcal vaccines show improved efficacy but still problematic: http://ow.ly/2e488

2 years ago...

Menveo meningococcal vaccine approved for children - ONA

oncologynurseadvisor.com — “Novartis announced that the FDA has approved Menveo (meningococcal [Groups A, C, Y and W-135] oligosaccharide diphtheria CRM197 conjugate vaccine) for active immunization to prevent invasive meningococcal disease caused by Neisseria meningitidis serogroups A, C, Y and W-135 in children 2--10 years of age.View full resource at oncologynurseadvisor.com

  • View Related
  • Share

Most Recently Shared on February 1, 2011 at 4:17 pm By:

The Top 3 resources shared on this topic. More resources.

Key stats and trends about this topic

Related Health Centers

Featuring the top 3 experts for this topic

Advertisement

Share via Email

Share this WisdomCard with others by embedding on your site or blog.

300x260

425x300

560x390